All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
2 warning events since 2019; the latest 2025-10-30.
From the record
Bioceres Crop Solutions Corp.'s filings since 2019 show 2 warning events: a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2025-10-30) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+28% a year over 9 filed years; profitable in 3 of 9.
From the record
Bioceres Crop Solutions Corp.'s 9 filed years say what it did: revenue went from $41 million in fiscal 2016 to $335 million in fiscal 2025, up 28% a year; it rose in 7 of 8 years; the deepest fall was 28% from fiscal 2024 to fiscal 2025; net income was positive in 3 of 9 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
Share count grew 14.3% a year. 6% of cash flow returned. Insiders: 0 sales, 0 purchases.
From the record
Over the 3 fiscal years to 2025-06-30, Bioceres Crop Solutions Corp.'s diluted share count grew about 14.3% a year, and dividends and buybacks returned about 6% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they doing right now?
Is it financially healthy right now?
ROE -20%: lost 20¢ per shareholder dollar. Leverage 61%: owes 61¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-06-30, Bioceres Crop Solutions Corp. lost about 20 cents for every dollar of shareholders' money, and gross profitability: its products earned about 17 cents per dollar of everything the company owns. Leverage: it owed about 61 cents per dollar of assets, and net share issuance: its share count grew 0.6% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 44% of 11 in its family; net margin -17.6%.
From the record
Bioceres Crop Solutions Corp.'s standing among 11 graded names in its industry family: revenue of $335 million in fiscal 2025 ranks in the bottom 32% by size; a net margin of -17.6% ranks in the bottom 32%; revenue growth of 0% a year over the last 3 filed years ranks in the top 32% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
SI estimate 5.0/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Bioceres Crop Solutions Corp.'s leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-04-20 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 6 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 7 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they set up to do next?
How much room does it have to grow?
top 34% of 11 in its family for room to expand.
From the record
Bioceres Crop Solutions Corp.'s room to grow, from the newest filed statements (fiscal 2025): cash of $33 million against no long-term debt tagged leaves 4.3% of its assets as net cash, top 25% of its family; cash from operations less capital spending is 13.2% of revenue (top 32%); a gross margin of 39.3% (top 15%); research spending of 4.5% of revenue (bottom 36%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 47% of 11 in its family for growth drivers.
From the record
Bioceres Crop Solutions Corp.'s growth drivers, from the filed years to fiscal 2025: revenue grew 0% a year over the last three filed years against 28% over all 9, slowing (bottom 14% of its family); the newest year grew -27.9% (bottom 14%); research spending grew 29% a year (top 21%); capital spending grew 17.7% a year (top 17%) (its annual reports). Bioceres Crop Solutions Corp. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 11% of 11 in its family for expectations against reality.
From the record
Bioceres Crop Solutions Corp.'s newest year against its own record: revenue of $335 million in fiscal 2025 came in 38.8% below the $548 million its prior three years' pace pointed to (bottom 23% of its family); net income of $59 million against a prior three-year average of $8 million (bottom 5%); a net margin of -17.6% against 1.7% before (bottom 5%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made